Denali Therapeutics Inc. Profile Avatar - Palmy Investing

Denali Therapeutics Inc.

Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151…
Biotechnology
US, South San Francisco [HQ]
DNLI/Financials
Supply · Problems · Premarket · Compliance

Supply Analysis

Supply Analysis